These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1361548)

  • 1. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
    Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
    J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
    Sabouraud A; Redureau M; Gires P; Martinet M; Scherrmann JM
    Drug Metab Dispos; 1993; 21(6):997-1002. PubMed ID: 7905405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.
    Hong G; Bazin-Redureau MI; Scherrmann JM
    J Pharm Sci; 1999 Jan; 88(1):147-53. PubMed ID: 9874717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fab fragments of ovine antibody to colchicine enhance its clearance in the rat.
    Peake PW; Pianta TJ; Succar L; Fernando M; Buckley NA; Endre ZH
    Clin Toxicol (Phila); 2015 Jun; 53(5):427-32. PubMed ID: 25858137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of digoxin-specific antibody fragments on digoxin disposition in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Biochem Pharmacol; 1987 Jul; 36(13):2215-20. PubMed ID: 3606637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of colchicine: a review of experimental and clinical data.
    Sabouraud A; Rochdi M; Urtizberea M; Christen MO; Achtert G; Scherrmann JM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():35-9. PubMed ID: 1449014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of colchicine.
    Hunter AL; Klaassen CD
    J Pharmacol Exp Ther; 1975 Mar; 192(3):605-17. PubMed ID: 1120958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.
    McClurkan MB; Valentine JL; Arnold L; Owens SM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.
    Eddleston M; Fabresse N; Thompson A; Al Abdulla I; Gregson R; King T; Astier A; Baud FJ; Clutton RE; Alvarez JC
    Clin Toxicol (Phila); 2018 Aug; 56(8):773-781. PubMed ID: 29334816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of enzyme-linked immunosorbent assays to study the plasma disposition of sheep polyclonal and rat monoclonal digoxin-specific Fab fragments in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1990 Aug; 42(8):572-6. PubMed ID: 1981586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine disposition in patients with familial Mediterranean fever with renal impairment.
    Ben-Chetrit E; Scherrmann JM; Zylber-Katz E; Levy M
    J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
    Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS quantification of free and Fab-bound colchicine in plasma, urine and organs following colchicine administration and colchicine-specific Fab fragments treatment in Göttingen minipigs.
    Fabresse N; Allard J; Sardaby M; Thompson A; Clutton RE; Eddleston M; Alvarez JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():400-406. PubMed ID: 28667924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
    Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
    Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragments.
    Sabouraud A; Urtizberea M; Grandgeorge M; Gattel P; Makula ME; Scherrmann JM
    Toxicology; 1991; 68(2):121-32. PubMed ID: 1891780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.
    Chappey ON; Niel E; Debray M; Wautier JL; Scherrmann JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1072-6. PubMed ID: 7562471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
    Valentine JL; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic disposition and toxicity of cationized goat immunoglobulin G and fab fragments in isolated perfused rat liver.
    Hong G; Bazin-Redureau M; Gires P; Scherrmann JM
    Drug Metab Dispos; 1998 Jul; 26(7):661-9. PubMed ID: 9660848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.